Celebrex Educational Campaign Or Name Change Expected By End Of May
Executive Summary
A decision on instituting a name change or educational campaign for Searle/Pfizer's Celebrex is expected by the end of May.
You may also be interested in...
Celebrex Name Keeps Drug Off Minnesota Health-System Formulary
The potential for Searle/Pfizer's arthritis therapy Celebrex to be confused with other products is keeping the drug off the formulary of Minneapolis-based Fairview Health Services, a hospital pharmacy director told a National Coalition on Health Care medical errors conference Feb. 22 in Washington, D.C.
Celebrex Name Keeps Drug Off Minnesota Health-System Formulary
The potential for Searle/Pfizer's arthritis therapy Celebrex to be confused with other products is keeping the drug off the formulary of Minneapolis-based Fairview Health Services, a hospital pharmacy director told a National Coalition on Health Care medical errors conference Feb. 22 in Washington, D.C.
Vioxx Strategy Aims To Switch Patients Up From OTC To Rx Market
Merck is looking to move patients out of the over-the-counter analgesic market to the prescription COX-2 inhibitor Vioxx, Merck Human Health-The Americas President David Anstice said at Merck's annual business briefing Dec. 9 in Whitehouse Station, N.J.